Thank you for your interest in partnering with Syantra.
Become part of our mission to make early cancer detection part of routine healthcare. Partnering with Syantra puts you at the forefront of a revolution in cancer detection and treatment as you will be part of connecting the world to our revolutionary patent-pending Onco-ID™.
Onco-ID enables the earliest possible detection of cancer and empowers oncologists and pharmaceutical scientists to create personalized, precision treatments for cancer.
We are on the cusp of the next wave in both cancer detection and treatment: the time to be aligned with Syantra is NOW. Clinical studies, collaborations, license agreements, investors: we would love to hear from you, and we look forward to connecting and sharing what we have in store for the future of cancer research, detection, and treatment.
Please contact us for more information about partnering with Syantra.
Awards
Even it its earliest stages, Syantra is enjoying recognition from peers in the healthcare, technology, and social arenas, including:
Project Achievement Award, Association of Professional Engineers and Geoscientists of Alberta (APEGA), March 2024 (for our platform)
Leader of the year Award to Dr. Tina Rinker (co-founder), Start Alberta, October 2023
Technology Innovation Award, BioAlberta, September 2023 (for our platform)
International Award to Dr. Tina Rinker(co-founder), City of Calgary, June 2023
Research Impact Award, Schulich School of Engineering, University of Calgary 2023
One to Watch Award, presented to Syantra Inc. by the A100 at the Start Alberta Tech Awards, 2021
Current key partners
Announcements & stories
News about Syantra and its revolutionary approach to cancer screening.
